Revolutionizing cancer treatment: The power of cell-based drug delivery systems

Area of Science:

• Biomedical Engineering
• Oncology
• Materials Science

Background:

• Intravenous drug delivery for cancer faces challenges like poor circulation, accumulation, and penetration to solid tumors.
• Biological barriers significantly limit the efficacy of conventional cancer therapies.
• Cell-based drug delivery platforms present a novel approach to overcome these limitations.

Purpose of the Study:

• To review emerging strategies for cell-mediated drug delivery in cancer treatment.
• To highlight the functions and advantages of cell-based platforms in overcoming biological barriers.
• To discuss challenges and opportunities for clinical translation of these advanced systems.

Main Methods:

• Review of current literature on cell-based drug delivery systems for cancer.
• Analysis of different cell-based strategies: cell membrane coating, intracellular loading, and extracellular backpacking.
• Exploration of advantages including prolonged circulation, active targeting, and controlled release.

Main Results:

• Cell-based platforms demonstrate enhanced drug delivery to tumors by overcoming biological barriers.
• These systems offer improved biocompatibility and controlled drug release mechanisms.
• Various cell-mediated strategies show potential for revolutionizing cancer diagnosis and treatment.

Conclusions:

• Cell-mediated drug delivery holds significant promise for advancing cancer therapy.
• Addressing technological, ethical, and financial barriers is crucial for clinical implementation.
• Integration of pharmaceuticals, medicine, and materials science is key for future development.